Liposarcoma: Molecular Genetics and Therapeutics
Authors:
Open Access
- 27 December 2010
- journal article
- review article
- Published by Hindawi Limited in Sarcoma
- Vol. 2011, 1-13
Abstract
Sarcomas are a group of heterogeneous tumours with varying genetic basis. Cytogenetic abnormalities range from distinct genomic rearrangements such as pathognomonic translocation events and common chromosomal amplification or loss, to more complex rearrangements involving multiple chromosomes. The different subtypes of liposarcoma are spread across this spectrum and constitute an interesting tumour type for molecular review. This paper will outline molecular pathogenesis of the three main subtypes of liposarcoma: well-differentiated/dedifferentiated, myxoid/round cell, and pleomorphic liposarcoma. Both the molecular basis and future avenues for therapeutic intervention will be discussed.Keywords
This publication has 169 references indexed in Scilit:
- The p53 orchestra: Mdm2 and Mdmx set the toneTrends in Cell Biology, 2010
- Targeting the HGF/Met signalling pathway in cancerEuropean Journal of Cancer, 2010
- Mad2 Prolongs DNA Damage Checkpoint Arrest Caused by a Double-Strand Break via a Centromere-Dependent MechanismCurrent Biology, 2010
- Genomic profiling reveals subsets of dedifferentiated liposarcoma to follow separate molecular pathwaysVirchows Archiv, 2009
- Effectiveness of Radiotherapy in Myxoid Sarcomas Is Associated With a Dense Vascular PatternInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Role of homologous recombination in trabectedin-induced DNA damageEuropean Journal of Cancer, 2008
- JUN Oncogene Amplification and Overexpression Block Adipocytic Differentiation in Highly Aggressive SarcomasCancer Cell, 2007
- Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin‐3AInternational Journal of Cancer, 2007
- Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 InteractionJournal of Medicinal Chemistry, 2006
- Mdm2 promotes the rapid degradation of p53Nature, 1997